A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults - Concepedia

Concepedia

Publication | Open Access

A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults

DOI Full Paper Access

18

Citations

45

References

2021

Year

Amy Bullock, Handan Gunduz‐Bruce, Gary Zammit, Min Qin, Haihong Li, Abdul J. Sankoh, Christopher Silber, Stephen Kanes, Jeffrey M. Jonas, James Doherty

Human Psychopharmacology Clinical and Experimental

Abstract

Zuranolone improved sleep measures versus placebo in a phase advance model of insomnia in healthy adults, supporting future studies in patients with insomnia disorder.

References

	Year	Citations

Page 1